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MAGNETIC RESONANCE IMAGING OF THE OVARY: 
CAN IT PREDICT LOW RESPONSE TO EMPIRIC SUPEROVULATION? 
Rebecca J. Crichton, Robert N. Troiano, David L. Keefe 
Department of Obstetrics and Gynecology, Yale University School of Medicine, 
New Haven, CT. 
The purpose of this pilot study was to evaluate whether or not there are 
morphologic differences in ovarian volume, follicular size and number, as seen on 
Magnetic Resonance Imaging (MRI), between the ovanes of women with low response to 
ovulation induction and younger women with presumably normal ovarian function. Five 
women with an average age of 42 and a documented low response to superovulation with 
human menopausal gonadotropins, indicated by a peak estradiol less than 500 pg/ml, 
underwent MRI on the third day of their cycles. Their images were compared to the day 
three MRUs of five controls with an average age of 25. There was no significant difference 
between the ovarian volumes in the two groups. There were, however, significant 
differences in follicle numbers. For follicles greater than or equal to 5 mm in diameter, 
there were 3.2±2.7 in the women with low response and 23.0±3.7 in the controls 
(p<0.0005). For follicles less than 5 mm in diameter, there were 20.2±7.0 in the low- 
responding women and 40.8±12.1 in the control group (p<0.01). In terms of total follicle 
numbers visualized on MRI, there were 23.4±7.0 in the women with low response and 
63.8+14.4 in the controls (p<0.001). These results indicate that MRI is indeed capable of 
measuring differences between reproductive subgroups. Further studies are necessary to 
evaluate the full potential of MRI to prospectively assess ovarian reserve. 
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Infertility, defined as the inability to conceive after one year of regular, unprotected 
intercourse, affects 14% of couples and 25% of women in the United States within their 
reproductive lifetimes.12 Although there has been no increase in rates of infertility over the 
past decade, there has indeed been a sharp escalation in the demand for infertility services.3 
Approximately 2.3% of all women of reproductive age, or 1.26 million women, now seek 
medical help for infertility in a given year. 23 This increase coincides with a number of 
factors, foremost of which is aging of the so-called baby boom generation, bom from 1946 
to 1964. Ages 32 to 50, these women represent a ground-breaking generation. They were 
the first to exert control over their fertility with birth control and liberalized abortion and 
among the first to enter the workplace full-time with equal expectations. Thus, by choice 
or circumstance, they have tended to marry at a later age and to postpone pregnancy. The 
causes of their infertility are many including male factor, tubal disease, endometriosis, and 
ovulation dysfunction, but, of particular interest, are the women with infertility of 
unknown cause. Unexplained infertility patients represent 10-12% of the infertile 
population4 5 and 24-28% of the couples at most fertility clinics.6 The major commonality 
within this group has been shown to be advanced female age.7 Because the causes of their 
infertility remain elusive, many of these reproductively older women undergo a host of 
costly, time-consuming, and emotionally challenging empiric treatments in hopes of 
pregnancy often with little knowledge of prognosis. 
It has long been recognized that fertility is compromised by advanced female age. 
Demographic studies have indicated that fertility peaks during the early 20s and decreases 
noticeably after age 30, with its greatest decrease after 35.8 Studies of women participating 
in donor insemination programs demonstrate two effects of aging.9 First, women over 31 
years of age take twice as long as women 20 to 31 to achieve pregnancy, and, second, the 
probability of women over 30 having a normal pregnancy and delivery, once pregnant, 
decreases by 3.5% per year. These findings have resulted in the estimation that a 35 year 
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old woman’s chance of having a healthy baby is half that of a 25 year old’s. Other authors 
estimate that conception rates undergo a fourfold reduction, while rates of spontaneous 
abortion approximately double by age 40.1011 Young couples having regular intercourse 
without contraception are expected to conceive at a rate of 20% per cycle, whereas w omen 
40-44 conceive at a rate of 5% per cycle. A further rapid decline in fertility in the 40s is 
observed to the point where only 2-5% of women between 45 and 49 deliver infants.12 
Studies of older women undergoing in vitro fertilization (IVF) have found that, although 
fertilization occurs at near normal rates, fewer oocytes are retrieved, fewer embryos are 
transferred, and pregnancy rates are lower in older than in younger women.10131415 Thus, 
age appears to disrupt oocyte developmental potential. Indeed, age is the best predictor of 
achieving pregnancy through IVF. 
Although the above studies demonstrate that women’s ability to conceive declines 
steadily with age, the mechanism underlying reproductive senescence in women remains 
emgmatic. Two loci of reproductive senescence have been proposed: ovarian function 
and/or competence of the uterus to sustain pregnancy. In recent years, the development of 
oocyte donation protocols has provided some resolution in the debate as to whether the 
decreased fertility in reproductively older women arises from uterine or ovarian factors. 
Most studies indicate that oocyte donation abrogates the effects of age on fertility.15161718 it 
is also important to note that while these results support a central role for oocytes in 
reproductive aging, they do not rule out utenne aging, because older women receiving 
donated oocytes receive progesterone replacement which could correct defective utenne 
receptivity.1920 Nonetheless, it appears that a central component of reproductive aging in 
women anses from dysfunctional oocytes, providing evidence that many older women with 
“unexplained infertility” may in fact have “oocyte factor infertility.” 
In the 1950s, a series of cadaveric studies of accident victims were performed by 
Erik Block in which the number of follicles per person were counted after ovanan 
histologic preparation.21 These studies verified that, despite wide individual variation. 
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overall, there is an inverse relationship between female age and the number ol ovarian 
primordial follicles. The morphology of the ovanes of the younger and older women were 
strikingly different, with the ovarian cortex of the young women’s ovary containing 
thousands of small primordial follicles and the older women’s ovary containing 
predominantly stroma and lacking follicles and corpora lutea.22 
Human ovanes are known to acquire a lifetime quota of oocytes before birth, 
peaking at 6-7 million oogoma at 16-20 weeks gestation. This store begins to dwindle 
shortly after it is established through a continual process of atresia. By puberty, the oocyte 
reserve is already reduced to 300,000. Ovulation explains the loss of only about 500 
follicles in a woman’s reproductive lifespan. Any of these 500 ovanan follicles destined to 
ovulate is denved from a cohort of nearly a thousand follicles at vanous stages of growth 
and atresia. This cohort, in turn, is derived from the pool of follicles onginally formed 
dunng fetal life. By menopause, only a few hundred follicles remain.23 
In comparing follicle numbers to menstrual history, Richardson et al. found that the 
mean number of primordial follicles in ovanes of women still regularly menstruating is ten 
times higher than in the penmenopausal women with irregular menses. In addition, follicles 
are virtually absent in postmenopausal ovaries.24 Her study reports that the rate of follicular 
loss accelerates dramatically in the last decade before menopause, which explains the nearly 
complete exhaustion of follicles at a median age of 51.3. Since menopause is the result of 
programmed disappearance of a limited reserve of follicles. Faddy et al. employed 
mathematical models based on the above total follicle counts at different ages to predict 
menopause.25 They found that follicular numbers declined bi-exponentially rather than as a 
simple exponential function of age, with the rate of loss greatly accelerating after follicle 
numbers reach a threshold of 25,000 at a median age of 37.5. 
It is important to note that the rate of reproductive aging vanes among individual 
women. Despite the menstrual irregulanties occumng in the penmenopausal penod, 
ovulation and conception may occur, albeit at reduced incidence rates and accompanied by 
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reduced oocyte fertility. Speroff et al. note that a 57 year and 120 day old woman 
conceived spontaneously.26 And, Faddy et al. further emphasize that menopause is a 
spectrum, unique to each individual.25 The Massachusetts Women’s Health Study finds 
that, for penmenopause, the median age of onset is 47.5, and the median duration is 4 
years. The median age of menopausal onset which is 51.3 is reduced by 1.5 years in 
smokers.27 Even natural menopause, confirmed by increased levels of plasma 
gonadotropins and decreased levels of peripheral estrogen, occurs before age 40 in 1% of 
women.28 Ovarian aging, thus, does not always correspond with chronological age. 
Given the spectrum of reproductive capacity at various ages, clinical tests of oocyte 
reserve are necessary to help women to decide whether to pursue costly therapies which 
depend on their own oocytes or whether to pursue alternatives such as oocyte donation or 
adoption. Currently, however, no accurate tests are available to diagnose oocyte infertility . 
The small size of the oocyte and its restricted availability for research nearly preclude the 
utility of direct oocyte assays. 
In contrast to the oocyte, the follicle is more amenable to clinical assays. 
Folliculogenesis, which clearly influences oocytes’ developmental competence, has been 
followed both physiologically by measuring hormonal fluctuations and anatomically by 
visualization with imaging modalities such as transvaginal ultrasound (US).29 A number of 
endocrinologic assays and challenge tests also have been employed to study the pituitary- 
ovarian axis during the early follicular phase as predictors of reproductive senescence.30 To 
date, day 3 follicle stimulating hormone (FSH) level has been most studied as a marker of 
the penmenopausal state.31 
The initiation of follicle growth occurs throughout the menstrual cycle 
independently of gonadotropin influence. A cohort of follicles then becomes responsive to 
gonadotropins and is propelled into further growth as the follicles develop gonadotropin 
sensitivity until they develop into antral follicles.32 FSH acts on developing follicles to 
stimulate estrogen and inhibin production, which exert negative feedback on FSH secretion 
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at the level of the hypothalamus and anterior pituitary gland. Diminished follicular reserve, 
as occurs with aging, leads to increased circulating FSH levels. As the dominant follicle 
becomes increasingly sensitive to FSH, it secretes increasing amounts of estradiol and 
inhibin. FSH level then drops below a threshold which can support less developed 
follicles, so they undergo atresia. This results in the emergence of a single dominant 
follicle.29 Elevated FSH levels during the early follicular phase is a highly specific but not 
sensitive marker of reproductive aging. 
Since no specific tests identify oocyte infertility, the first line of therapy for a 
substantial proportion of infertile patients involves empiric superovulation with human 
menopausal gonadotropins (hMGs). By extending the period during which the level of 
FSH remains above the threshold level, multiple ovulations can be achieved with 
pharmacologic administration of gonadotropins.33 34 This allows additional follicles in the 
cohort to achieve a stage of maturity that enables them to respond to a preovulatory LH 
discharge and ovulate. If this fails, IVF and related technologies are tried.35 These 
treatments, however, are costly, require daily injections, and have the possible side effects 
of multiple gestation and ovarian hyperstimulation. 
Whereas conception rates with hMG-hCG superovulation vary from a monthy high 
of 80% in women with hypothalamic amenorrhea, they approach zero in women above age 
40.35 In randomized, controlled clinical trials, the monthly pregnancy rate in couples with 
unexplained infertility undergoing empiric superovulation with FSH agonists is 10-15% 
which compares favorably to their baseline pregnancy rate of only 3% per spontaneous 
cycle.3637 Cumulative pregnancy rates in women over 40 were less than 8%.38 
Individual patients respond differently in terms of peripheral IE, levels, number and 
size of recruited follicles, and outcome, even though they are stimulated with the same type 
and dosage of stimulatory medications.39 So-called “poor” or “low response” have peak Ej 
levels under 500 pg/ml, poor follicular recruitment in terms of number and size, a high 
cycle cancellation rate due to insufficient response, and a poor history of low response to a 
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standard stimulation protocol. The frequency of this condition increases as a function of 
age, suggesting that it may be a variety ol reproductive senescence. Early identilication of 
these patients with low response is critical, not only to individualize protocols in order to 
maximize chances of pregnancy, but also to counsel patients more effectively so as to give 
them realistic expectations and to allow for investigation of alternatives as soon as 
possible.40 41 
Since outcomes of IVF and ovulation induction are strongly dependent on ovarian 
responsiveness to exogenous stimulation, many authors have proposed methods of 
predicting poor ovanan response to artificial reproductive technologies in order to avoid the 
unnecessary risks and emotional and financial expense incurred by the patient during these 
treatments. However, none of these prognostic methods are universally employed. Jacobs 
et al. showed that with advancing age, there is, on average, a significant reduction in 
response to hMGs in terms of preovulatory Ej level, the number of preovulatory follicles 
less than 15 mm, and cancellation rate. The E2 level per follicle, however, remained 
unaltered, indicating that, perhaps, the health of the follicular apparatus remained intact.42 
The authors note that the size of the follicle store and of superior response obtained with 
exogenous hormones varied markedly between individuals of similar age and even between 
siblings, and, thus, that age alone has limited predictive value for patient counselling or 
clinical management. Day 3 FSH has been suggested to be predictive of outcome and to 
provide an index of functional ovanan reserve as defined by poor gonadotropin 
responsiveness and pregnancy rates.43 44 However, large intercycle vanability as well as 
large mterinstitutional variability in laboratory results makes its use problematic.45 46 These 
same problems pertain to the FSH:LH ratio, recently found to increase before FSH alone.47 
The vanation in FSH and the observation that some low-responding patients have normal 
day 3 FSH levels led to the proposal of ovanan performance predictive tests such as the 
clomiphene citrate challenge test and the gonadotropin releasing hormone agonist (GnRH- 
a) stimulation test.4849 While both are reasonably specific, they lack sensitivity, their results 

7 
are not immediately available, and, again, the results are dependent on individual lab 
standards. Theoretically, low-responding patients could be prospectively identified using a 
combination of the above variables, but, clinically, identification into different response 
groups is done retrospectively after the patient undergoes at least one cycle of IVF or 
ovulation induction. 
Thus, there is not yet a standardized method to assess ovarian reserve or to predict 
outcome failure with hMGs. The relatively low efficiency of ovulation induction and IVF 
in producing viable pregnancies would be improved by accurate predictions of outcome that 
would allow termination of superovulation protocols unlikely to succeed. Since there is 
considerable evidence that ovarian morphology closely reflects ovarian function, an 
anatomic approach might be feasible. Magnetic resonance imaging (MRI), until now, has 
had little role in reproductive endocrinology. Using the older techmques of a body coil and 
conventional spin-echo sequence, ovanan morphology, as seen on MRI, was initially 
described as heterogeneous on T-2 weighted images.50 However, with new advances in 
MRI, like multiple phased-array coils and fast spin-echo, imaging times have decreased and 
soft tissue resolution and contrast have dramatically increased.51 52 53 54 Even 
postmenopausal ovaries can now be seen on most pelvic MRIs.55 
MRI has the advantages of being noninvasive and using no ionizing radiation. In 
addition, it provides multiplanar capacity allowing for reproducible examination of anatomy 
in three-dimensions and a field of view unimpeded by bone, bowel, or fat. For these 
reasons, MRI is quickly becoming the imaging modality of choice for the evaluation of the 
pelvic mass.56 Simple ovanan cysts can be differentiated from other lesions, and greater 
detail can be visualized within follicles than with other imaging modalities. MRI has been 
shown to be superior to transabdominal US in the visualization of ovanes in the female 
pelvis with distorted anatomy.57 Wiczyk et al. note that, in addition to showing that MRI 
can accurately track folliculogenesis in spontaneous and stimulated cycles, MRI 
demonstrates a secondary cohort of follicles, ranging in size from 0.3-0.8 cm, undetected 
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by transabdominal US.58 MRI now provides the clear delineation of individual follicles, 
cortex, and stroma as well as the relative distribution of follicles.59 
It is not yet known whether or not ovanan architecture is an indicator of a woman’s 
fertility status, or, similarly, whether or not loss of oocyte function is reflected in this 
architecture. In trying to assess ovanan follicular reserve, MRI is a unique tool in that it is 
nomnvasive, safe, and provides exquisite anatomic detail in a reproducible and quantitative 
fashion. 
STATEMENT OF PURPOSE 
Given the recent developments in MRI, this study is intended to assess the utility of 
MRI as a prognostic tool in the management of infertility. As a pilot study, its purpose is 
to evaluate whether or not there are morphologic differences, as viewed by MRI, between 
the ovaries of women with a low response to superovulation and women with presumably 
normal ovarian function. In doing so, ovanan volume and follicle size and number will be 
compared between the two distinct groups. 
METHODS 
Part I: Validation Exercises 
In order to validate the approach of assessing ovanan size and follicular number and 
size with MRI, qualitative and roughly quantitative compansons were made, first, between 
in vitro MRI images of an excised human ovary and its histologic sections and, second, 
between in vivo MRI images of an ovary pnor to surgical removal and its histologic 
sections. 
The in vitro examination was performed using MRI parameters developed by 
radiologists Dr. Robert Troiano and Dr. Shirley McCarthy that could be applicable to in 
vivo studies. These parameters were selected to obtain the smallest possible field of view 
(FOV) while maintaining high resolution. They included a repetition time (TR) of 4000 
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msec, an echo time (TE) of 90 msec, FOV of 16 cm, a section thickness of 3 mm, an 
intersection spacing of 0, an echo train length (ETL) of 16, number of excitations (NEX) ot 
4, and a matrix of 256 x 256. A general purpose circular coil was utilized because of the 
inherently small size of the ovary. Histologic sectioning and staining of the specimen 
previously imaged was performed by Dr. Harvey Kliman, a gynecologic pathologist. 
Sectioning was done in the approximate plane of the MR images. 
The in vivo experiment was performed with the voluntary help of a 36 year old, 
premenopausal woman in Dr. David Keefe’s Reproductive Endocrinology Clinic with 
intractable pelvic pain thought to be secondary to severe endometriosis. One day prior to 
her scheduled total abdominal hysterectomy with right salpingo-oophrectomy, she was 
imaged using MRI. In the operating room, a landmarking stitch was placed on the lateral 
edge of the ovary prior to removal. After removal, oocytes were harvested from the distal 
half of the ovary for the purposes of another study. The ovary was deemed free, of gross 
pathology and then fixed in formalin, embedded in parafin wax, and serially sectioned 
along the sagittal plane by Dr. Vimta Parkash of the Yale Pathology Department. The 
approximation of sectioning to the MR images was done by Dr. Parkash and me by lining 
up the anatomic landmark of a right hydrosalpinx and the placed stitch. Slice thickness was 
5 microns, and every tenth slice was stained with hematoxylin-eosin stain. 
Part II: MR Imaging of Controls vs. Women with Low Responses 
Experimental Subjects and Study Design 
The protocol for the study was approved by the Human Investigation Committee of 
the Yale University School of Medicine, and all subjects I recruited gave verbal and written 
consent as informed and willing parti pants. 
The five patient subjects were selected because they had demostrated a low 
response (i.e. peak Ej^OO pg/ml) to empiric superovulation using 3 or 4 ampules hMG 
daily. All patient subjects had previously undergone routine fertility screening at the Yale 
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Center for Reproductive Medicine and were diagnosed as having unexplained and/or age- 
related infertility, in the case of 4 patients, or anovulation, in the case of one patient. Their 
mean age was 42 years (range 36-45); they were all nulliparous and nonobese; and their 
mean duration of infertility was 39 months (range 29-54). The 4 patients with unexplained 
infertility had regular menses every 25-28 days, while the woman with a diagnosis of 
anovulation menstruated irregularly every' 40-60 days. They had been followed at the Yale 
clinic for a mean follow-up time of approximately 12.6 months (range 9-20). Each woman 
had a documented day 3 FSH within one and one-half years of being recruited into the 
study of less than 12 mlU/mL. However, subsequent to having the MRI, one patient 
control had a basal day 3 FSH of 19.0. None of the patients noted hypoestrogemc 
symptoms. 
For the pilot study, the first three control studies were of paid participants in a prior 
radiologic study. Thus, little is known of their histories, except that they were Yale-New 
Haven Hospital employees, were nulliparous, had regular menses (every 25-32 days), and 
had not taken oral contraceptive medications within the past six months. To complete the 
control group, two medical student volunteers were recruited. They too were nulliparous, 
had regular menses, and used barrier contraception. In addition, they had no known 
medical or gynecologic illness, nor did they take any medications. The average age of the 
five control subjects was 25 years (range 21-29). 
I scheduled 11 study subjects for MR imaging on day 3 or 4 of their menstrual cycle 
before they received any stimulatory medications. I followed the three patient subjects 
undergoing ovulation induction the month of the MRI for peak E2, follicular number and 
size on transvaginal US, and outcome. 
MR Imaging 
Before entering the MRI, each subject underwent a screening questionnaire to 
ensure that they did not have any contraindications to the procedure. For the MRI, each 
patient had an empty bladder and was positioned lying on the ventral side. 

All images of the pelvis were obtained using a phased-array multicoil. Following a 
coronal localizer of each woman’s ovaries, multiplanar (sagittal, coronal, and axial), last 
spin-echo T-2 weighted sequences were performed. The imaging parameters were TR 
5000-7500 msec, TE 117 msec, FOV 20 cm, NEX 4, matrix 256 x 256, ETL 16, 
bandwidth (BW) 32, and a slice thickness of 3 mm with a 0 mm gap. There was no use of 
gadolinium contrast. 
Image Analysis 
A cross-sectional radiologist. Dr. Robert Troiano, at Yale-New Haven Hospital and 
I reviewed the MR images. Measurements of ovarian diameters were made in three 
orthogonal dimensions from the axial, sagittal, and/or coronal planes. If simple follicular 
cysts were present, their diameters, too, were measured in three orthogonal dimensions. 
Follicle numbers and diameters were recorded for all follicles greater than or equal to 5 
mm. The greatest diameter was determined by comparing the multiplanar images and 
taking into account the 3 mm slice thickness so as not to over or undercount. Follicles that 
had distinct fluid-filled antrums but were less than 5 mm in diameter were also totalled in 
each patient. All measurements were made using calipers and were made from basement 
membrane to basement membrane. Finally, examinations were assessed for pelvic 
pathology. 
Data Analysis 
I calculated ovarian volume using the formula for a prolate ellipse, 
V=(1/2)(A)(B)(C), while calculating the volumes of simple follicular cysts using the 
equation for a more spherical object, V=(rc/6)(A)(B)(C), where A, B, and C are the largest 
diameters measured in three planes.60 58 To give a more accurate measure of ovarian tissue 
present, in the cases in which cysts were present, I calculated ovarian volume by 
subtracting the cystic volumes from the ovarian volume calculated above using the total 
ovarian dimensions. Statistical comparisons between the two subject groups for ovarian 

volumes and follicle numbers were made using the Student’s t-test. P<0.05 was 
considered significant. 
Finally, I compared the number of follicles visualized on day 3 MRI in our study to 
the number of follicles greater than 1 mm observed by Erik Block in his post-mortem, gold 
standard ovarian dissections for each of the distinct age groups studied.21 The mean 
number of follicles greater than or equal to 1 mm for two distinct age groups in Block’s 
study was determined by averaging the number of these follicles in each of the women he 
studied with an average age of death of 25 (n=12) and in each of the women with an 
average age of death of 42 (n=7). Again, a Student’s t-test was used to compare our means 
to his, p=0.05. 
RESULTS 
Part I: Validation Exercises 
Recent advances in T-2 weighted MR imaging techniques permit delineation of the 
ovaries, both in vitro and in vivo. As seen in the in vitro MRI comparison to histologic 
sectioning of Figure 1, the fluid-filled antral follicles demonstrate high signal intensity, 
while the fibrous capsule appears as a low signal intensity nm. The remainder of the 
ovarian stroma is usually of moderate signal intensity, isomtense with fat. Despite a subtle 
shift in the cutting plane and distortion of follicle shape by sectioning. Figure 1 provides 
reassurance that the MR images are consistent with actual anatomy in terms of follicular 
size, location, and number. The antral follicles are approximately spherical and, for the 
most part, are located near the ovarian surface. 
The smallest structures distinguished without magnification on the in vivo MRI, 
seen in Figure 2, were the 0.5-1.0 mm antrums of developing or atretic follicles. In the 
corresponding histologic sections, these small antral follicles could likewise be seen, 
confirming that follicle size and number were analogous to the imaged ovarian cross- 
sections. Under light microscopy, the smallest structures visualized within the ovarian 
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tissue were the 50-55 micron primordial follicles. Lacking the hypenntense antrums, these 
small structures were not seen on the corresponding MRI. 
Figure 1: MR image slice of an excised human ovary in vitro with its 
corresponding histologic section. 
Figure 2: MR image of a human ovary 
in vivo with its corresponding histologic 
section, prepared one day later. 
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Part II: MR Images of Controls vs. Women with Low Responses 
Total scan times for the multiplanar MR views of each woman’s ovaries averaged 
30 minutes per subject. All MR examinations were well-tolerated by study participants. 
In viewing the pelvic MRI’s, findings included the identification of an involuted 
corpus luteum as well as a small amount of adenomyosis in the uterus of one control 
subject and the presence of simple cysts in three out of five of the low-responding patient 
subjects. These cysts were unilocular, fluid-filled, and with diameters of approximately 2 
cm. In order to compare amounts of ovarian tissue in the control versus low-responding 
patient groups, these cystic volumes were subtracted from the total volume within the 
ovarian capsule. This calculation resulted in the ovarian volumes recorded in Table 1. The 
differences in the mean ovarian volumes (Figure 3), with average volumes of 8.4 cm3 ± 
3.5 cm3 in the younger control group and of 5.0 cm3 ± 4.3 cm3 in patients with a low 
response, were not signicant (p>0.1). With cystic volumes included, the mean ovanan 
volume for the low-responding patients was 6.7 cm3. 
Subject 
Controls 
2 3 5 
R L R L R L R L R L 
Ovarian Vol. (cm3) 8.4 8.1 12.0 13.0 6.9 13.9 4.5 7.2 5.5 4.0 
Follicles<5mm 9 24 10 20 33 28 21 20 17 22 
Follicles>5mm 10 14 16 8 14 14 12 9 9 9 
Subject 
“Low Responders” 
6 7 8 9 10 
R L R L R L R L R L 
Ovarian Vol. (cm3) 2.4 14.8 2.6 3.8 1.7 10.5 4.2 4.8 2.2 2.7 
Follicles<5mm 12 11 12 18 15 6 2 11 6 8 
Follicles^5mm 0 0 1 2 2 4 0 6 0 1 
Table 1: Ovarian volumes and follicle numbers less than and greater than 
or equal to 5mm in each control and low-responding subject, as seen on 
noninvasive, T-2 weighted, FSE MR images. R=right ovary; L=left ovary. 
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Figure 3: Mean ovarian volumes ± standard deviation, determined by 
measurements of MR images, in the control versus low-responding 
subjects. No significant difference was present. 
















Figure 4: Mean total number of follicles per person ± standard deviation in 
the control versus the low-responding patient subjects. The darker part of 
each column corresponds to the mean number of follicles greater than or 
equal to 5 mm, while the lighter part corresponds to the number of follicles 
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less than 5 mm. For total number of follicles, p<0.001. For follicle 
numbers > 5 mm, p<0.0005. For follicle numbers < 5 mm, p<0.01. 
Follicle numbers, visualized on day 3 MRI, within each subject’s ovary are 
recorded in Table 1. Mean numbers of follicles per person for the the control group and 
low-responding patient group are divided into less than and greater than or equal to 5 mm 
and are represented in Figure 4. The mean total number of follicles for the controls and the 
low-responding patients were 63.8± 14.4 and 23.4±7.0, respectively. This represented a 
significant difference, with pcO.OOl. There was likewise a significant difference 
(p<0.0005) between the two groups in terms of mean number of follicles greater than or 
equal to 5 mm. The control group had 23.0±3.7 of these, while the low-responding group 
had only 3.2±2.7. In terms of mean number of follicles less than 5 mm visualized in each 
group, there were 40.8±12.1 in the controls and 20.2±7.0 in the “low responders.” This 
represented a significant difference, pxO.Ol. For the most part, the smallest follicles 
counted in the less than 5 mm range had antral diameters just under 1 mm. The bulk of 
these, however, were in the range of 1-3 mm but were difficult to measure exactly. 
Lastly, a comparison is made between the number of follicles visualized on day 3 
MRI and the post-mortem, histologic follicle counts done by Block in 1952 (see Figure 5). 
For the control group with an average age of 25, there was a mean number of 63.8±14.4 
total follicles seen on MRI and a mean number of 72.7±32.5 Graafian follicles greater than 
1 mm observed by Block. For the 42 year old age group, there was a mean number of 
23.4±7.0 total follicles seen on MRI and a mean number of 17.0+30.0 follicles greater than 
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Figure 5: Comparisons between Block’s histologic assessments of mean 
follicle numbers greater than 1 mm in diameter ± standard deviation and the 
mean number of follicles visualzed on MRI ± standard deviation for each of 
the study’s distinct age groups. Bars represent standard deviations. No 
significant difference between age-matched groups. 
It is interesting to note that in the three low-responding patients who went on to 
pursue unsuccessful ovulation induction the cycle of their day 3 MRI, only a fraction of the 
follicles seen on MRI were picked up on the day 3 transvaginal US. In the first patient 
with 23 follicles less than 5 mm in diameter and a cyst of 2.5 cm diameter, 5 follicles less 
than 10 mm were seen on US. In the second patient with 30 follicles less than 5 mm and 3 
follicles between 5 and 10 mm on MRI, no follicles were seen on US. And, for the third 
patient with 21 follicles less than 5 mm and 6 follicles 5-7 mm as well as 3 cysts on MRI, 6 
follicles less than 10 mm and 2 cysts were recorded on transvaginal US. 
DISCUSSION 
With the new techniques of the phased-array multicoil and fast spin-echo, MRI 
provides enough anatomic detail to reliably assess antral follicle position, size, and number. 
This imaging modality was validated both in vitro and in vivo before pursuing comparison 
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betw een the infertility patients and controls. Not only was there good approximation 
between histologic section and MR images, there was agreement between our MRI data and 
Block’s post-mortem, histologic follicle counts.21 Both data sets indicate that the number ol 
antral follicles greater than 1 mm declines with advancing age. It is interesting to note that 
the variances for Block’s data are much larger than our own. Perhaps, this is due to the 
fact that his selection process was more random than our own process of recruiting hospital 
employees and medical students with presumably normal ovarian function and infertility 
patients specifically with documented low reponse to ovulation induction. 
MRI also provided nomnvasive estimation of ovarian volume both in terms of 
rough histological comparison and the findings of other studies. Using MRI, Outwater and 
Mitchell determined that in 38 premenopausal women the mean ovarian volume was 9.6 
mL ± 10.1 mL and that in 14 postmenopausal women the mean ovarian volume was 2.5 
mL ± 2.6 mL.61 Thus, as would be expected, our 25 year old control group have large 
ovaries typical of premenopausal women, while the women with documented low response 
and still menstruating show slightly smaller ovaries, though not as small as in 
postmenopausal women. 
The significant differences in total numbers of follicles, follicles less than 5 mm in 
diameter, and follicles greater than or equal to 5 mm in diameter, observed on MRI, 
between the younger control group and the older infertility patients with low' response to 
ovulation induction suggests that MRI is capable of documenting the differences expected 
with chronological aging. How much these differences are affected by reproductive, or 
biologic, aging will require the study of age-matched controls of proven fertility. 
Nonetheless, there is an indication that MRI may be useful in the estimation of ovarian 
reserve. 
Since it remains unclear what causes decline in oocyte number and quality with 
aging, most current studies of the subject, like this one, are observational in nature. They 
display a correlation. These observations are potentially useful to women. 
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indistinguishable by traditional parameters, and physicians in that they could serve as 
screening mechanisms to more effectively direct patients to appropriate counselling and 
treatment. Large numbers of studies and correlations with outcome are necessary to 
establish the threshold for a new screening test. Further study is also necessary to clarify 
whether individual variations in the size and dynamics of the follicular pool arises from 
postnatal environmental influences, like the proven bad effects of cigarette smoking or 
ionizing radiation, or is determined during oogenesis in the fetus or even genetically , prior 
to conception. 
Despite the unknown and likely multiple factors affecting follicle attrition and 
oocyte dysfunction, observations of follicular reserve have the potential, for now, to 
provide new insight into the management of unexplained infertility. A large part of the role 
of reproductive endocrinologists is, one, to speed up the time required for successful 
gestation, if possible, and, two, to provide realistic expectations of couples’ reproductive 
potential. Before menopause, it seems that many women will experience a phase of 
subfertility lasting approximately a decade or less.30 Yet, during this phase, menstrual 
cycles will usually continue, often in a regular fashion with ovulation. As increasing 
numbers of women attempt childbearing between the ages of 35 and 50, it would be 
beneficial to be able to prospectively distinguish between outcome categories, to better 
assess biologic rather than chonologic age, and to predict low response to ovulation 
induction early on in therapy. It may be, for instance, that, although little is known about 
the intrinsic modulators of follicular recruitment and depletion in humans, the number of 
follicles available for potential recruitment into further growth and development with 
hMG’s is proportional to the number of antral follicles 2-4 mm and just able to be seen on 
MRI.33'34 
The effectiveness of treatment is only one component of therapy decisions. Also 
important are the cost of the individual treatments, the time required to participate in therapy 
programs, the severity of potential side effects, and the individual characteristics of each 
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woman. From the point of view of cost, a thorough MRI of the pelvis is approximately 
$1000. This is in the context of the cost of hMG mediction alone which is $1000-1500 per 
cycle. In addition, there are lab, physician, and US ($200 per scan) fees each cycle. The 
cost of the more invasive IVF procedures exceeds $10,000 per cycle, with many women 
attempting six or more cycles. 
Despite the high cost of MRI, it has the potential, if proven to be an accurate 
indicator of ovarian reserve, for one complete 30-minute ovarian exam to preclude or 
minimize treatment costs. No other nonmvasive techniques can accomplish imaging of the 
adnexa in as precise and reproducible a fashion as MRI. US, for example, suffers from 
less spatial resolution and lack of reproducibility in the plane of the transducer held by the 
sonographer. While fairly good at recording the mid-size, preovulatory follicles, US 
seems to miss the larger smaller cohort of antral follicles, seen in the early follicular phase, 
also observed by Block on histologic section and Wiczyk in comparing same day MRI and 
US images.2158 While the spatial resolution of US is adequate in only two planes and the 
ovaries are not always optimally visualized, MRI has adequate spatial resolution in all 
planes, has unsurpassed tissure resolution, and can be used to readily locate ovaries. In 
general, structure is typically easier to discern on MRI than US. As yet, however, neither 
US nor MRI can define the primordial or preantral follicle as can histologic examination. 
This study points to many exciting areas for future research. To our knowledge, no 
systemic study of normal ovarian anatomy in three-dimensions, as seen on MRI versus US 
versus histology, has been performed. With more accurate land-marking of ovarian tissues 
during removal, better orientation of MR and histologic sections could be achieved, making 
possible more detailed comparison of MR images to histology with computerized image 
analysis. 
In order to verify that MRI reveals differences in response to superovulation and 
provides a marker for reproductive aging, it would be helpful to do a study comparing the 
low-responding patients with age-matched controls of proven fertility. MRI could then be 

used to look for a correlation to the spectrum of response to various treatment protocols 
seen in women with unexplained infertility to empiric superovulation. As diagnostic 
procedures improve and understanding increases, the heterogeneous group of women with 
unexplained infertility may become smaller. Their diagnoses will be more subtle and 
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